{"title":"≥20岁美国成年人吸烟与脂质/脂蛋白浓度的关系","authors":"Ram B Jain, Alan Ducatman","doi":"10.1177/1849454418779310","DOIUrl":null,"url":null,"abstract":"<p><p>Cross-sectional data from National Health and Nutrition Examination Survey for the years 1999-2012 for those aged ≥20 years, fasting for at least 8 h, and classified as smokers and nonsmokers on the basis of observed serum cotinine levels were used to evaluate the impact of smoking on the adjusted and unadjusted concentrations of low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, total cholesterol (TC), and triglycerides (TG). Adjustments were made for the effects of gender; race/ethnicity; survey year; dietary intake of alcohol; caffeine; cholesterol; saturated, unsaturated, and total fatty acids; fasting time; body mass index; and poverty income ratio. Adjusted levels of LDL and TC did not vary among smokers and nonsmokers. Smokers had lower adjusted levels of HDL than nonsmokers (48.8 vs. 51.4 mg/dL, <i>p</i> < 0.01) and higher adjusted levels of TG (124.4 vs. 111.9 mg/dL, <i>p</i> < 0.01) than nonsmokers. Adjusted odds of smokers having abnormal levels were 1.6 (95% confidence interval (CI) 1.4-1.8) for HDL, 1.2 (95% CI 1.1-1.4) for TC, and 1.3 (95% CI 1.2-1.5) for TG. Males had lower adjusted levels than females for HDL (45.2 vs. 55.4 mg/dL, <i>p</i> < 0.01) and TC (191.3 vs. 196.6 mg/dL, <i>p</i> < 0.01) but higher adjusted levels than females for TG (126.3 vs. 110.1 mg/dL, <i>p</i> < 0.01) and LDL (114.4 vs. 112.6 mg/dL, <i>p</i> = 0.02). A unit increase in body mass index was associated with 1.4% decrease in the adjusted levels of HDL, 0.18% increase in the adjusted levels of LDL, and a 2.3% increase in the adjusted levels of TG.</p>","PeriodicalId":37524,"journal":{"name":"Journal of Circulating Biomarkers","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2018-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1849454418779310","citationCount":"47","resultStr":"{\"title\":\"Associations between smoking and lipid/lipoprotein concentrations among US adults aged ≥20 years.\",\"authors\":\"Ram B Jain, Alan Ducatman\",\"doi\":\"10.1177/1849454418779310\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Cross-sectional data from National Health and Nutrition Examination Survey for the years 1999-2012 for those aged ≥20 years, fasting for at least 8 h, and classified as smokers and nonsmokers on the basis of observed serum cotinine levels were used to evaluate the impact of smoking on the adjusted and unadjusted concentrations of low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, total cholesterol (TC), and triglycerides (TG). Adjustments were made for the effects of gender; race/ethnicity; survey year; dietary intake of alcohol; caffeine; cholesterol; saturated, unsaturated, and total fatty acids; fasting time; body mass index; and poverty income ratio. Adjusted levels of LDL and TC did not vary among smokers and nonsmokers. Smokers had lower adjusted levels of HDL than nonsmokers (48.8 vs. 51.4 mg/dL, <i>p</i> < 0.01) and higher adjusted levels of TG (124.4 vs. 111.9 mg/dL, <i>p</i> < 0.01) than nonsmokers. Adjusted odds of smokers having abnormal levels were 1.6 (95% confidence interval (CI) 1.4-1.8) for HDL, 1.2 (95% CI 1.1-1.4) for TC, and 1.3 (95% CI 1.2-1.5) for TG. Males had lower adjusted levels than females for HDL (45.2 vs. 55.4 mg/dL, <i>p</i> < 0.01) and TC (191.3 vs. 196.6 mg/dL, <i>p</i> < 0.01) but higher adjusted levels than females for TG (126.3 vs. 110.1 mg/dL, <i>p</i> < 0.01) and LDL (114.4 vs. 112.6 mg/dL, <i>p</i> = 0.02). A unit increase in body mass index was associated with 1.4% decrease in the adjusted levels of HDL, 0.18% increase in the adjusted levels of LDL, and a 2.3% increase in the adjusted levels of TG.</p>\",\"PeriodicalId\":37524,\"journal\":{\"name\":\"Journal of Circulating Biomarkers\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-05-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1177/1849454418779310\",\"citationCount\":\"47\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Circulating Biomarkers\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/1849454418779310\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2018/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Circulating Biomarkers","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/1849454418779310","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2018/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 47
摘要
使用1999-2012年全国健康与营养调查(National Health and Nutrition Examination Survey)中年龄≥20岁、禁食至少8小时、根据观察到的血清可替宁水平分为吸烟者和非吸烟者的横断面数据,评估吸烟对调整和未调整的低密度脂蛋白(LDL)胆固醇、高密度脂蛋白(HDL)胆固醇、总胆固醇(TC)和甘油三酯(TG)浓度的影响。对性别的影响作了调整;种族/民族;调查;饮食中酒精的摄入量;咖啡因;胆固醇;饱和脂肪酸、不饱和脂肪酸和总脂肪酸;禁食时间;身体质量指数;和贫困收入比。调整后的LDL和TC水平在吸烟者和非吸烟者之间没有差异。吸烟者的HDL调节水平低于不吸烟者(48.8 vs. 51.4 mg/dL, p < 0.01), TG调节水平高于不吸烟者(124.4 vs. 111.9 mg/dL, p < 0.01)。吸烟者HDL水平异常的校正几率为1.6(95%可信区间(CI) 1.4-1.8), TC为1.2 (95% CI 1.1-1.4), TG为1.3 (95% CI 1.2-1.5)。男性的HDL (45.2 vs. 55.4 mg/dL, p < 0.01)和TC (191.3 vs. 196.6 mg/dL, p < 0.01)的调节水平低于女性,但TG (126.3 vs. 110.1 mg/dL, p < 0.01)和LDL (114.4 vs. 112.6 mg/dL, p = 0.02)的调节水平高于女性。体重指数每增加一个单位,HDL调整水平降低1.4%,LDL调整水平升高0.18%,TG调整水平升高2.3%。
Associations between smoking and lipid/lipoprotein concentrations among US adults aged ≥20 years.
Cross-sectional data from National Health and Nutrition Examination Survey for the years 1999-2012 for those aged ≥20 years, fasting for at least 8 h, and classified as smokers and nonsmokers on the basis of observed serum cotinine levels were used to evaluate the impact of smoking on the adjusted and unadjusted concentrations of low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, total cholesterol (TC), and triglycerides (TG). Adjustments were made for the effects of gender; race/ethnicity; survey year; dietary intake of alcohol; caffeine; cholesterol; saturated, unsaturated, and total fatty acids; fasting time; body mass index; and poverty income ratio. Adjusted levels of LDL and TC did not vary among smokers and nonsmokers. Smokers had lower adjusted levels of HDL than nonsmokers (48.8 vs. 51.4 mg/dL, p < 0.01) and higher adjusted levels of TG (124.4 vs. 111.9 mg/dL, p < 0.01) than nonsmokers. Adjusted odds of smokers having abnormal levels were 1.6 (95% confidence interval (CI) 1.4-1.8) for HDL, 1.2 (95% CI 1.1-1.4) for TC, and 1.3 (95% CI 1.2-1.5) for TG. Males had lower adjusted levels than females for HDL (45.2 vs. 55.4 mg/dL, p < 0.01) and TC (191.3 vs. 196.6 mg/dL, p < 0.01) but higher adjusted levels than females for TG (126.3 vs. 110.1 mg/dL, p < 0.01) and LDL (114.4 vs. 112.6 mg/dL, p = 0.02). A unit increase in body mass index was associated with 1.4% decrease in the adjusted levels of HDL, 0.18% increase in the adjusted levels of LDL, and a 2.3% increase in the adjusted levels of TG.
期刊介绍:
Journal of Circulating Biomarkers is an international, peer-reviewed, open access scientific journal focusing on all aspects of the rapidly growing field of circulating blood-based biomarkers and diagnostics using circulating protein and lipid markers, circulating tumor cells (CTC), circulating cell-free DNA (cfDNA) and extracellular vesicles, including exosomes, microvesicles, microparticles, ectosomes and apoptotic bodies. The journal publishes high-impact articles that deal with all fields related to circulating biomarkers and diagnostics, ranging from basic science to translational and clinical applications. Papers from a wide variety of disciplines are welcome; interdisciplinary studies are especially suitable for this journal. Included within the scope are a broad array of specialties including (but not limited to) cancer, immunology, neurology, metabolic diseases, cardiovascular medicine, regenerative medicine, nosology, physiology, pathology, technological applications in diagnostics, therapeutics, vaccine, drug delivery, regenerative medicine, drug development and clinical trials. The journal also hosts reviews, perspectives and news on specific topics.